Browsing by Author VICTOR NURCOMBE

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Showing results 18 to 26 of 26 < previous 
Issue DateTitleAuthor(s)
2007Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cellsRider, D.A.; Nalathamby, T.; Nurcombe, V. ; Cool, S.M. 
2006Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cellsLing, L.; Murali, S.; Dombrowski, C.; Haupt, L.M.; Nurcombe, V. ; Cool, S.M. ; Stein, G.S.; Van, Wijnen A.J.
2007Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial modelWoodruff, M.A. ; Rath, S.N.; Susanto, E.; Hutmacher, D.W. ; Haupt, L.M.; Nurcombe, V. ; Cool, S.M. 
2007Temporal and functional changes in glycosaminoglycan expression during osteogenesisNurcombe, V. ; Goh, F.J.; Haupt, L.M.; Murali, S.; Cool, S.M. 
2006Temporal expression of proteoglycans in the rat limb during bone healingSong, S.J.; Nurcombe, V. ; Cool, S.M. ; Hutmacher, D. 
2007The in vivo assessment of a novel scaffold containing heparan sulfate for tissue engineering with human mesenchymal stem cellsLuong-Van, E.; Song, S.; Nurcombe, V. ; Cool, S. ; Grondahl, L.
Sep-2005The osteoblast-heparan sulfate axis: Control of the bone cell lineageCool, S.M. ; Nurcombe, V. 
2006The use of heparan sulfate to augment fracture repair in a rat fracture modelJackson, R.A.; Nurcombe, V. ; Cool, S.M. ; McDonald, M.M.; Little, D.G.
2009Wnt signaling controls the fate of mesenchymal stem cellsLing, L.; Nurcombe, V. ; Cool, S.M.